Evidence map›Paper›PMID 30076526›Full record

ArticleMolecular neurobiology2019

AT2R Activation Prevents Microglia Pro-inflammatory Activation in a NOX-Dependent Manner: Inhibition of PKC Activation and p47

Shahnawaz Ali Bhat, Anika Sood, Rakesh Shukla, Kashif Hanif

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. CXCR6 orchestrates brain CD8Nature immunology · 2023
    Article
  10. Angiotensin Type 2 Receptor Pharmacological Agonist Relieves Neurocognitive Deficits via Reducing Neuroinflammation and Microglial Engulfment of Dendritic Spines.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. The Angiotensin ATPharmacological reviews · 2022
    Review
  20. Microglia as Therapeutic Target for Radiation-Induced Brain Injury.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shahnawaz Ali BhatDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India.
Anika SoodNational Institute of Pharmaceutical Education and Research, Rae Bareli, India.
Rakesh ShuklaDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India.
Kashif HanifDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India. k_hanif@cdri.res.in.ORCID http://orcid.org/0000-0001-6088-6024
Central Drug Research Institute · INNational Institute of Pharmaceutical Education and Research · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR4021/MED/30/676/2011)
6 · The paper itself

Abstract

Microglia-induced reactive oxygen species (ROS) production and inflammation play an imperative role in neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD). It has been established that angiotensin II type-2 receptor (AT2R) activation is neuroprotective in central nervous system diseases like stroke and AD. However, the involvement of AT2R in NADPH oxidase (NOX)-mediated microglia activation is still elusive. Therefore, the present study investigated the role of AT2R in angiotensin II (Ang II) or Phorbol 12-myristate 13-acetate (PMA)-induced microglia activation in BV2 cells, primary microglia, p47

Indexed as

Angiotensin IIAnimalsCell LineGlycogen Synthase Kinase 3 betaInflammationLipopolysaccharidesMiceMicrogliaMitochondriaNADPH OxidasesNeuronsNF-E2-Related Factor 2Oxidative StressPhosphorylationProtein Kinase CProtein Phosphatase 2Angiotensin IIGlycogen Synthase Kinase 3 betaLipopolysaccharidesNADPH Oxidasesneutrophil cytosolic factor 1Nfe2l2 protein, mouseNF-E2-Related Factor 2Protein Kinase CProtein Phosphatase 2Reactive Oxygen SpeciesReceptor, Angiotensin, Type 2Tetradecanoylphorbol AcetateAT2 receptorMicrogliaNADPH oxidaseNeuroinflammationPP2AReactive oxygen species

Identifiers

PMID30076526
OpenAlexW2887700372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.